GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
50.33
-0.08 (-0.16%)
Nov 6, 2026, 4:00 PM EST - Market closed
GSK Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 101,263 | 98,521 | 68,786 | 75,295 | 70,343 | 108,945 | |
Market Cap Growth | 7.53% | 43.23% | -8.64% | 7.04% | -35.43% | 19.45% |
Enterprise Value | 128,591 | 117,428 | 84,175 | 92,667 | 87,835 | 147,418 |
Last Close Price | 50.33 | 47.81 | 31.62 | 33.35 | 30.42 | 37.25 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.64 | 12.81 | 21.34 | 12.00 | 3.90 | 18.35 |
PS Ratio | 2.27 | 2.24 | 1.75 | 1.95 | 1.99 | 3.26 |
PB Ratio | 4.15 | 4.59 | 4.20 | 4.62 | 5.78 | 3.77 |
P/FCF Ratio | 10.20 | 11.45 | 10.66 | 10.84 | 9.33 | 11.49 |
P/OCF Ratio | 8.49 | 9.46 | 8.38 | 8.73 | 7.89 | 10.12 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.89 | 2.67 | 2.14 | 2.40 | 2.49 | 4.41 |
EV/EBITDA Ratio | 8.43 | 7.70 | 8.08 | 6.92 | 7.84 | 14.04 |
EV/EBIT Ratio | 9.45 | 9.24 | 10.86 | 8.66 | 9.96 | 19.32 |
EV/FCF Ratio | 12.96 | 13.65 | 13.04 | 13.34 | 11.65 | 15.55 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.30 | 1.12 | 1.30 | 1.41 | 2.08 | 1.13 |
Debt / EBITDA Ratio | 2.03 | 1.54 | 1.99 | 1.68 | 2.22 | 3.12 |
Debt / FCF Ratio | 3.21 | 2.78 | 3.30 | 3.30 | 3.35 | 3.45 |
Net Debt / Equity Ratio | 1.14 | 0.90 | 1.00 | 1.00 | 1.28 | 0.90 |
Net Debt / EBITDA Ratio | 1.81 | 1.27 | 1.57 | 1.21 | 1.39 | 2.48 |
Net Debt / FCF Ratio | 2.81 | 2.25 | 2.53 | 2.34 | 2.07 | 2.74 |
Asset Turnover | 0.50 | 0.54 | 0.53 | 0.51 | 0.42 | 0.31 |
Inventory Turnover | 1.42 | 1.54 | 1.58 | 1.58 | 1.72 | 1.36 |
Quick Ratio | 0.55 | 0.50 | 0.50 | 0.60 | 0.66 | 0.53 |
Current Ratio | 0.86 | 0.82 | 0.78 | 0.89 | 0.91 | 0.79 |
Return on Equity (ROE) | 28.27% | 43.31% | 22.80% | 46.38% | 31.31% | 16.68% |
Return on Assets (ROA) | 9.63% | 9.79% | 6.53% | 8.82% | 6.57% | 4.41% |
Return on Invested Capital (ROIC) | 25.65% | 28.45% | 20.35% | 30.29% | 20.14% | 13.48% |
Return on Capital Employed (ROCE) | 20.10% | 23.80% | 16.40% | 22.10% | 19.60% | 10.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.67% | 7.81% | 4.69% | 8.34% | 25.62% | 5.45% |
FCF Yield | 9.80% | 8.73% | 9.38% | 9.23% | 10.72% | 8.70% |
Dividend Yield | 3.58% | 3.62% | 4.53% | 3.98% | 4.23% | 4.98% |
Payout Ratio | 63.26% | 44.86% | 94.91% | 45.60% | 23.18% | 91.20% |
Buyback Yield / Dilution | 1.37% | 0.60% | -0.75% | -0.66% | -0.79% | -0.55% |
Total Shareholder Return | 4.95% | 4.22% | 3.78% | 3.32% | 3.44% | 4.43% |